Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Cash & Equivalents (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Cash & Equivalents came in at $5.4 million in Q1 2026, up 328.07% YoY from $1.3 million in Q1 2025, and up 7956.72% on a QoQ basis from $67000.0 in Q4 2025.

Abpro Holdings (ABPO) Cash & Equivalents (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Cash & Equivalents data on file, last reported at $5.4 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 328.07% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 328.07% YoY) and the FY2025 annual result came in at $67000.0, down 49.24% from the prior year.
  • Cash & Equivalents grew to $5.4 million in Q1 2026, from $67000.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $5.4 million in Q1 2026 to a low of $1000.0 in Q3 2024.
  • A 5-year average of $890385.1 and a median of $336784.5 in 2022 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents plunged 99.89% — and 2025, when it soared 34200.0%.
  • Tracing ABPO's Cash & Equivalents over 5 years: stood at $392446.0 in 2022, then jumped by 119.39% to $861000.0 in 2023, then tumbled by 84.67% to $132000.0 in 2024, then slumped by 49.24% to $67000.0 in 2025, then surged by 7956.72% to $5.4 million in 2026.
  • The last three Cash & Equivalents figures came in at $5.4 million (Q1 2026), $67000.0 (Q4 2025), and $343000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - 4.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.40 Mn
Dec 31, 2025 67,000.00
Sep 30, 2025 343,000.00
Jun 30, 2025 2.01 Mn
Mar 31, 2025 1.26 Mn
Dec 31, 2024 132,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 202,000.00
Mar 31, 2024 220,000.00
Dec 31, 2023 861,000.00
Sep 30, 2023 948,153.00
Mar 31, 2023 295,224.00
Dec 31, 2022 392,446.00
Mar 31, 2022 330,569.00